The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SILDENAFIL GH; SILDENAFIL LAPL; SILDENAFIL LUPIN (Generic Health Pty Ltd)
Product name
SILDENAFIL GH; SILDENAFIL LAPL; SILDENAFIL LUPIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
147 (255 working days)
Active ingredients
sildenafil citrate
Registration type
New generic medicine
Indication
SILDENAFIL GH; SILDENAFIL LAPL; SILDENAFIL LUPIN (film-coated tablet) is indicated for the treatment of erectile dysfunction in adult males. SILDENAFIL GH; SILDENAFIL LAPL; SILDENAFIL LUPIN is not indicated for use by women.